GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $14.97 $17.43 Thursday, 18th Apr 2024 CPRX stock ended at $15.34. This is 4.13% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 6.00% from a day low at $15.33 to a day high of $16.25.
90 days $13.12 $17.50
52 weeks $11.09 $17.77

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
2021-09-16 $5.02 $5.02 $4.87 $4.97 553 337
2021-09-15 $4.89 $5.02 $4.87 $5.00 918 532
2021-09-14 $5.03 $5.03 $4.88 $4.90 709 964
2021-09-13 $5.04 $5.13 $4.98 $4.99 817 555
2021-09-10 $5.04 $5.16 $4.95 $5.01 896 505
2021-09-09 $5.02 $5.23 $5.01 $5.06 655 852
2021-09-08 $5.19 $5.21 $4.98 $5.06 989 515
2021-09-07 $5.25 $5.39 $5.15 $5.19 864 543
2021-09-03 $5.47 $5.47 $5.20 $5.25 1 081 325
2021-09-02 $5.59 $5.64 $5.45 $5.47 805 183
2021-09-01 $5.54 $5.68 $5.54 $5.60 532 555
2021-08-31 $5.50 $5.61 $5.45 $5.51 602 640
2021-08-30 $5.47 $5.58 $5.42 $5.49 600 352
2021-08-27 $5.39 $5.51 $5.28 $5.47 872 587
2021-08-26 $5.53 $5.56 $5.31 $5.35 790 252
2021-08-25 $5.56 $5.66 $5.51 $5.52 722 705
2021-08-24 $5.69 $5.73 $5.53 $5.59 730 909
2021-08-23 $5.59 $5.72 $5.57 $5.70 879 736
2021-08-20 $5.42 $5.62 $5.40 $5.51 923 641
2021-08-19 $5.62 $5.70 $5.46 $5.46 710 262
2021-08-18 $5.71 $5.86 $5.65 $5.67 512 091
2021-08-17 $5.71 $5.75 $5.60 $5.71 678 854
2021-08-16 $6.04 $6.04 $5.71 $5.71 932 462
2021-08-13 $6.00 $6.24 $5.94 $6.04 1 493 453
2021-08-12 $5.94 $5.99 $5.83 $5.97 489 500
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT